New Zealand markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
236.10-1.01 (-0.43%)
At close: 04:00PM EDT
236.00 +0.34 (+0.14%)
Pre-market: 05:06AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 35.11B
Enterprise value 35.75B
Trailing P/E 45.28
Forward P/E 37.88
PEG ratio (5-yr expected) 3.41
Price/sales (ttm)9.86
Price/book (mrq)10.45
Enterprise value/revenue 9.99
Enterprise value/EBITDA 29.94

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-15.55%
S&P500 52-week change 3-2.16%
52-week high 3301.34
52-week low 3189.40
50-day moving average 3222.29
200-day moving average 3235.02

Share statistics

Avg vol (3-month) 3578.43k
Avg vol (10-day) 3531.3k
Shares outstanding 5146.42M
Implied shares outstanding 6N/A
Float 8145.08M
% held by insiders 10.82%
% held by institutions 166.98%
Shares short (28 Jul 2022) 41.84M
Short ratio (28 Jul 2022) 43.42
Short % of float (28 Jul 2022) 41.42%
Short % of shares outstanding (28 Jul 2022) 41.26%
Shares short (prior month 29 Jun 2022) 41.39M

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 40.74%
Trailing annual dividend rate 31.68
Trailing annual dividend yield 30.71%
5-year average dividend yield 41.05
Payout ratio 431.70%
Dividend date 321 Sept 2022
Ex-dividend date 416 Aug 2022
Last split factor 22:1
Last split date 330 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 21.78%
Operating margin (ttm)27.96%

Management effectiveness

Return on assets (ttm)12.73%
Return on equity (ttm)24.96%

Income statement

Revenue (ttm)3.58B
Revenue per share (ttm)24.50
Quarterly revenue growth (yoy)4.40%
Gross profit (ttm)2.06B
EBITDA 1.12B
Net income avi to common (ttm)779.44M
Diluted EPS (ttm)5.30
Quarterly earnings growth (yoy)-0.00%

Balance sheet

Total cash (mrq)273.71M
Total cash per share (mrq)1.87
Total debt (mrq)917.55M
Total debt/equity (mrq)27.30
Current ratio (mrq)2.80
Book value per share (mrq)22.95

Cash flow statement

Operating cash flow (ttm)351.15M
Levered free cash flow (ttm)117.35M